Clinical Trial for Oral Formula of Vanillin and Wheat Germ Oil for Treatment of Mild and Moderate COVID-19 Viral Disease
Status:
Recruiting
Trial end date:
2022-04-01
Target enrollment:
Participant gender:
Summary
- The study is a randomized clinical trial to assess a natural formula of vanillin & wheat
germ oil to treat and stop the clinical progression of COVID-19.
- The study aims to treat people with mild-to-moderate COVID-19 before their cases become
severe.
- The study duration is a 5-day experimental intervention and an extended 4 weeks follow
up.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Alexandria University
Collaborators:
Assoc. Prof. Ayman Baeis Dr. Noha Alaa Eldine Hassan Hamdy Ph. Hanya Hesham Sweilam